Bellerophon Announces Poster Presentation at Upcoming American Thoracic Society 2022 International Conference

Rhea-AI Summary

Bellerophon Therapeutics (Nasdaq: BLPH) announced a poster presentation at the ATS 2022 International Conference, scheduled for May 17, 2022. The session, titled "It's not just about IPF," will feature research on a Phase 2 Trial of INOpulse in patients with Sarcoidosis Associated Pulmonary Hypertension requiring supplemental oxygen. The presentation will be made by Dr. Robert Baughman from the University of Cincinnati at 2:15 PM Pacific Time in the Moscone Center, San Francisco.

The ePoster will be available on the conference's viewing site.

WARREN, N.J., May 12, 2022 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today announced a poster presentation at the upcoming American Thoracis Society (ATS) 2022 International Conference, being held May 13-18, 2022, in San Francisco, CA.

Presentation Details

• Session C103: It's not just about IPF
• Poster Title: A Phase 2 Trial of INOpulse in Patients with Sarcoidosis Associated Pulmonary Hypertension (SAPH) Requiring Supplemental Oxygen
• Presenter – Robert Baughman, M.D., Professor of Medicine at the University of Cincinnati
• Date/Time – Tuesday, May 17, 2022, at 2:15 PM Pacific Time
• Location – Room 9-10 (South Building, Exhibition Level), Moscone Center
  

The ePoster will be released on the day of presentation, will be available in the ePoster Viewing Site and accessible to conference attendees. Additional details can be found at the ATS 2022 website.

About Bellerophon
Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative therapies that address significant unmet medical needs in the treatment of cardiopulmonary diseases. The Company is currently developing multiple product candidates under its INOpulse® program, a proprietary pulsatile nitric oxide delivery system. For more information, please visit www.bellerophon.com.

Contacts

LifeSci Advisors:

Brian Ritchie

(212) 915-2578

britchie@lifesciadvisors.com

FAQ

What is the date and time for the BLPH presentation at ATS 2022?

The Bellerophon Therapeutics presentation is scheduled for May 17, 2022, at 2:15 PM Pacific Time.

Where will the BLPH presentation take place during ATS 2022?

The presentation will take place at Room 9-10 (South Building, Exhibition Level) in the Moscone Center, San Francisco.

Who is presenting the BLPH poster at the ATS 2022 conference?

The poster will be presented by Dr. Robert Baughman, a Professor of Medicine at the University of Cincinnati.

What is the focus of BLPH's poster presentation at ATS 2022?

The focus is on a Phase 2 trial of INOpulse in patients with Sarcoidosis Associated Pulmonary Hypertension requiring supplemental oxygen.

When will the ePoster for the BLPH presentation be available?

The ePoster will be released on the day of the presentation, May 17, 2022.